Asxl1 Gene Disruption Boosts T-cell Immunotherapy
Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most.
Publisher: Mirage
UT-ORII announces two new UT-ORNL research initiatives
The University of Tennessee-Oak Ridge Innovation Institute, or UT-ORII, has selected circular bioeconomy systems and radiopharmaceutical therapies as its two newest Convergent Research Initiatives (CRIs), areas of joint research for UT and Oak Ridge National Laboratory. Over the next five years, UT and Oak Ridge National Laboratory, or ORNL, will invest $40 million-$20 million per… Read More
Advanced Cancer: Bowel Obstruction Treatment Guidance from New Trial
Findings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obstruction (MBO) provide important evidence to help inform clinical decision-making in managing this frequent complication in patients with advanced cancer.
Vanderbilt Mobile Vaccine Program recognized by American Association of Nurse Practitioners
Christian Ketel and Carrie Plummer, both associate professors of nursing, were recognized by the American Association of Nurse Practitioners for their stewardship and successful outcomes of the Vanderbilt Mobile Vaccine Program. These leaders have also received Vanderbilt’s 2022 Martin Luther King, Jr. Award, the Health and Wellness Award from the Hispanic Family Foundation and the 2022 John W. Runyan Community Nursing Award from the University… Read More
DOE scientists deploy creativity, speed to disrupt COVID-19
In early 2020, when the novel coronavirus was gaining momentum but had not yet been named a pandemic, computational chemist Marti Head of Oak Ridge National Laboratory – along with scientists and researchers around the globe – abruptly switched her focus to the fight against COVID-19.